Physician
Lawrence and Memorial Hospital, INC.
Lawrence and Memorial Hospital, INC. was paid $1.55M by Medicaid between Jan 2018 and Aug 2023, across 141 billing codes. Its largest line is 96374, Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance — 9.0% of everything it billed.
33Billing provider infoLAWRENCE AND MEMORIAL HOSPITAL, INC.
NEW LONDON, CT 06320
NEW LONDON, CT 06320
33aNPI1073530879assigned 07/16/2006
33bProvider typeEmergency Medicine Physician
28Total paid$1.55M
24GClaims86,004
24DCodes billed141
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Emergency Medicine Physician providers in Connecticut
Rank by total paid#12 of 92
Median peer was paid$10K
This provider vs. median156×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WRINN, JACQUELINE controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,610 | $867K | |
| 2019 | 36,539 | $643K | |
| 2020 | 174 | $15K | |
| 2021 | 424 | $18K | |
| 2022 | 186 | $8K | |
| 2023 | 71 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9.0% | 1,395 | 1,034 | $140K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8.6% | 1,099 | 827 | $134K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7.7% | 3,165 | 2,121 | $120K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.7% | 2,663 | 2,320 | $104K |
| 36415 | Collection of venous blood by venipuncture | 6.1% | 6,241 | 4,090 | $95K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5.2% | 509 | 439 | $81K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.8% | 2,812 | 2,457 | $75K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.7% | 6,683 | 4,441 | $57K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.3% | 2,398 | 1,977 | $51K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.2% | 545 | 270 | $50K |
| 82962 | 3.1% | 3,470 | 1,930 | $48K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.0% | 594 | 501 | $47K |
129 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.9% | 3,313 | $45K |
| 71046 | Radiologic examination, chest; 2 views | 2.4% | 2,334 | $37K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.3% | 858 | $36K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.3% | 631 | $35K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.9% | 2,511 | $29K |
| 81001 | 1.5% | 1,912 | $24K | |
| 80053 | Comprehensive metabolic panel | 1.5% | 3,283 | $23K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.4% | 112 | $22K |
| 82550 | 1.3% | 1,170 | $20K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 861 | $19K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.1% | 142 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 214 | $16K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 574 | $15K |
| 84484 | <1% | 2,305 | $13K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 120 | $12K |
| 83735 | <1% | 1,433 | $11K | |
| G0659 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes | <1% | 127 | $10K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 219 | $9K |
| 83690 | <1% | 747 | $9K | |
| 80061 | Lipid panel | <1% | 179 | $7K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 467 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,094 | $6K |
| C1769 | Guide wire | <1% | 46 | $6K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 204 | $6K |
| 84703 | <1% | 334 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,006 | $6K |
| 72100 | <1% | 169 | $5K | |
| 85610 | <1% | 789 | $5K | |
| G0378 | Hospital observation service, per hour | <1% | 1,108 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 179 | $4K |
| 86850 | <1% | 328 | $4K | |
| 96376 | <1% | 175 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,681 | $3K |
| 87077 | <1% | 364 | $3K | |
| 99152 | <1% | 222 | $3K | |
| 83605 | <1% | 435 | $3K | |
| 97162 | <1% | 609 | $3K | |
| 85027 | <1% | 473 | $3K | |
| 73630 | <1% | 107 | $3K | |
| 82248 | <1% | 205 | $3K | |
| 73564 | <1% | 88 | $3K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $3K |
| 84450 | <1% | 726 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 138 | $2K |
| 82565 | <1% | 396 | $2K | |
| 83880 | <1% | 128 | $2K | |
| 73502 | <1% | 78 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 276 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,777 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,138 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 26 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 44 | $2K |
| 82310 | <1% | 111 | $2K | |
| 73030 | <1% | 68 | $1K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 26 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 106 | $1K |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 265 | $1K |
| 85007 | <1% | 201 | $1K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 26 | $1K |
| 82947 | <1% | 190 | $1K | |
| 76770 | <1% | 43 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 105 | $1K |
| 93017 | <1% | 223 | $1K | |
| 84132 | <1% | 232 | $1K | |
| 82374 | <1% | 104 | $998.35 | |
| 84295 | <1% | 195 | $921.11 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 82 | $828.25 |
| 82435 | <1% | 104 | $793.56 | |
| 71250 | <1% | 25 | $752.70 | |
| 82728 | <1% | 28 | $669.88 | |
| 73610 | <1% | 15 | $656.62 | |
| 93971 | <1% | 71 | $650.14 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,542 | $638.08 |
| 87070 | <1% | 33 | $556.09 | |
| 87186 | <1% | 300 | $553.53 | |
| 97116 | <1% | 233 | $529.13 | |
| 86900 | <1% | 333 | $499.63 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 15 | $497.59 |
| 86901 | <1% | 333 | $414.40 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 71 | $406.76 |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 13 | $343.46 |
| 86618 | <1% | 28 | $297.85 | |
| 81003 | <1% | 12 | $280.30 | |
| J3490 | Unclassified drugs | <1% | 140 | $263.71 |
| 83540 | <1% | 31 | $210.22 | |
| 85379 | <1% | 42 | $201.94 | |
| 84520 | <1% | 109 | $190.47 | |
| 83550 | <1% | 30 | $180.00 | |
| 97166 | <1% | 69 | $159.42 | |
| 92567 | <1% | 53 | $159.37 | |
| 86140 | <1% | 62 | $144.17 | |
| 87040 | <1% | 269 | $129.69 | |
| G0384 | Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 40 | $77.17 |
| 94664 | <1% | 32 | $60.61 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 16 | $48.45 |
| 87205 | <1% | 12 | $44.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 493 | $36.94 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 585 | $35.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,858 | $14.02 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 816 | $12.16 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 511 | $8.30 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 621 | $3.84 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 543 | $3.13 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 528 | $3.08 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 608 | $1.64 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 273 | $1.42 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 363 | $1.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 214 | $0.64 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 195 | $0.57 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 52 | $0.41 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | <1% | 27 | $0.23 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 16 | $0.13 |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 15 | $0.11 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 292 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 191 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 149 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 35 | $0.00 |
| Q9954 | Oral magnetic resonance contrast agent, per 100 ml | 0% | 55 | $0.00 |
| 76937 | 0% | 13 | $0.00 | |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 0% | 16 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 54 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 123 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 455 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 153 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 95 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 109 | $0.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | 0% | 20 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 20 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWRINN, JACQUELINE (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Yale New Haven Hospital | New Haven, CT | $1.08B |
| Bridgeport Hospital | Bridgeport, CT | $287.34M |
| Lawrence and Memorial Hospital, INC. | New London, CT | $136.19M |
| Greenwich Hospital | Greenwich, CT | $46.42M |
| Bridgeport Hospital | Milford, CT | $15.60M |
| LMW Healthcare INC. | Westerly, RI | $13.10M |
| Yale New Haven Hospital | New Haven, CT | $629K |
| LMW Healthcare INC. | Westerly, RI | $492K |
| Bridgeport Hospital | Bridgeport, CT | $398K |
| Lawrence and Memorial Hospital, INC. | New London, CT | $365K |
| Shoreline Endoscopy Center, LLC | Guilford, CT | $19K |
| Yale New Haven Hospital | New Haven, CT | $860.83 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.